PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 25 filers reported holding PROTEON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $132,000 | +1550.0% | 8,062 | -74.8% | 0.00% | – |
| Q3 2019 | $8,000 | +166.7% | 31,984 | +2565.3% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 1,200 | -45.9% | 0.00% | – |
| Q2 2018 | $5,000 | – | 2,218 | +1674.4% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 125 | -97.9% | 0.00% | – |
| Q4 2017 | $11,000 | – | 5,928 | +4642.4% | 0.00% | – |
| Q3 2017 | $0 | – | 125 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 125 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 125 | -95.5% | 0.00% | – |
| Q4 2016 | $5,000 | +66.7% | 2,782 | +827.3% | 0.00% | – |
| Q3 2016 | $3,000 | -82.4% | 300 | -73.1% | 0.00% | – |
| Q4 2015 | $17,000 | +325.0% | 1,117 | +273.6% | 0.00% | – |
| Q3 2015 | $4,000 | -60.0% | 299 | -45.5% | 0.00% | – |
| Q2 2015 | $10,000 | -16.7% | 549 | -50.7% | 0.00% | – |
| Q4 2014 | $12,000 | – | 1,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 315,101 | $599,000 | 25.51% |
| Abingworth LLP | 2,017,872 | $3,632,000 | 3.04% |
| Pharmstandard International S.A. | 1,165,344 | $2,214,000 | 1.91% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $1,868,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,332,599 | $2,532,000 | 0.10% |
| Perceptive Advisors | 334,116 | $635,000 | 0.04% |
| Baker Brothers Advisors | 389,394 | $740,000 | 0.01% |
| WEDBUSH SECURITIES INC | 17,000 | $32,000 | 0.01% |
| FINANCIAL COUNSELORS INC | 50,000 | $95,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 11,499 | $21,000 | 0.00% |